S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q4 2021

Deep Track Capital

Period: Q4 2021 Β· Filed: 2022-02-14
View on SEC EDGAR β†—
AUM
$1.42B
Total portfolio value
Positions
55
Reported securities
Top Holding
KROS
5.4% $76.1M
QoQ Changes
+0 / -0
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
KROSKEROS THERAPEUTICS INC$76.1M5.37%$58.51$11.26-80.8%
5.4%
TVTXTRAVERE THERAPEUTICS INC$76.0M5.37%$31.04$56.92+83.4%
5.4%
BCYCBICYCLE THERAPEUTICS PLC$67.0M4.73%$60.87$4.35-92.8%
4.7%
ISEEIVERIC BIO INC$66.9M4.72%β€”β€”
4.7%
JAZZJAZZ PHARMACEUTICALS PLC$63.7M4.50%$127.40$243.47+91.1%
4.5%
GBTGLOBAL BLOOD THERAPEUTICS IN$58.5M4.13%β€”β€”
4.1%
BEAMBEAM THERAPEUTICS INC$55.8M3.94%$79.69$34.79-56.3%
3.9%
CRNXCRINETICS PHARMACEUTICALS IN$54.0M3.81%$28.41$42.23+48.6%
3.8%
RPTXREPARE THERAPEUTICS INC$44.3M3.13%β€”β€”
3.1%
MDGLMADRIGAL PHARMACEUTICALS INC$42.4M2.99%$84.74$528.10+523.2%
3.0%
FDMT4D MOLECULAR THERAPEUTICS IN$41.7M2.94%$21.94$13.00-40.8%
2.9%
NVCRNOVOCURE LTD$41.3M2.92%$75.08$17.20-77.1%
2.9%
IMVTIMMUNOVANT INC$40.7M2.87%$8.52$38.79+355.3%
2.9%
KDNYCHINOOK THERAPEUTICS INC$39.5M2.79%β€”β€”
2.8%
KURAKURA ONCOLOGY INC$35.7M2.52%$14.00$11.10-20.7%
2.5%
DICEDICE THERAPEUTICS INC$33.9M2.40%β€”β€”
2.4%
JNCEJOUNCE THERAPEUTICS INC$33.4M2.36%β€”β€”
2.4%
ESPRESPERION THERAPEUTICS INC NE$28.2M1.99%$5.00$3.16-36.8%
2.0%
DYNDYNE THERAPEUTICS INC$27.3M1.92%$11.89$23.07+94.0%
1.9%
VRDNVIRIDIAN THERAPEUTICS INC$26.4M1.87%$19.77$19.40-1.9%
1.9%
FATEFATE THERAPEUTICS INC$24.5M1.73%$58.51$2.92-95.0%
1.7%
RNAMAVIDITY BIOSCIENCES INC$23.8M1.68%β€”β€”
1.7%
ACADCALLACADIA PHARMACEUTICALS INC$23.3M1.65%$23.34$25.97+11.3%
1.6%
GRTSQGRITSTONE BIO INC$22.8M1.61%β€”β€”
1.6%
SLNSILENCE THERAPEUTICS PLC$22.7M1.60%$23.89$10.39-56.5%
1.6%
TCDAQTRICIDA INC$22.3M1.58%β€”β€”
1.6%
MGTAMAGENTA THERAPEUTICS INC$21.6M1.52%β€”β€”
1.5%
SAGESAGE THERAPEUTICS INC$21.3M1.50%β€”β€”
1.5%
PASGPASSAGE BIO INC$20.4M1.44%$127.00$4.68-96.3%
1.4%
KALVKALVISTA PHARMACEUTICALS INC$19.8M1.40%$13.23β€”
1.4%

Quarter-on-Quarter Activity

New Positions

None this quarter

Exited Positions

None this quarter

Increased

None this quarter

Trimmed

None this quarter

← Back to Hedge Funds
Deep Track Capital Q4 2021 13F Filing β€” Holdings & Portfolio | MarketsFN